Stephen D. Nimer, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was named Researcher of the Year by BioFlorida, an association for the state’s life sciences industry.
Dean Stoios was named chief financial officer at The Wistar Institute.
Purdue University renamed its pediatric cancer research center the Tyler Trent Pediatric Cancer Research Center within the Purdue Institute for Cancer Research.
MDsave has begun its annual campaign to reduce the cost of 2D and 3D screening mammograms.
The Senate confirmation hearing for NCI Director Monica Bertagnolli, who has been nominated for the job of NIH director, has been scheduled for Oct. 18.
Katalin Karikó (left) and Drew Weissman (right)Photo credit: Niklas Elmehed © Nobel Prize OutreachKatalin Karikó and Drew Weissman were jointly awarded the 2023 Nobel Prize in Physiology or Medicine “for their discoveries concerning base modifications that enabled the development of effective mRNA vaccines against COVID-19.”
Moungi Bawendi (left), Louis Brus (center) and Alexei Ekimov (right)Photo credit: Niklas Elmehed © Nobel Prize OutreachMoungi G. Bawendi, Louis E. Brus, and Alexei I. Ekimov were jointly awarded the 2023 Nobel Prize in Chemistry for their discovery and development of quantum dots—nanoparticles so tiny that their size determines their properties. These smallest components of nanotechnology now spread their light from televisions and LED lamps, and can also guide surgeons when they remove tumor tissue, among many other applications.
Andrew Mesecar, Distinguished Professor of Biochemistry and the Walther Professor in Cancer Structural Biology, was named assistant vice president for research and director of the Purdue Institute for Cancer Research after serving, since Aug. 2022, as interim director. Mesecar was chosen for the position after a nationwide search.
Bradley Monk was named medical director of late-phase clinical research at Florida Cancer Specialists & Research Institute, LLC. Monks plans to leverage his experience and leadership across all tumor types as FCS expands in footprint in late-phase practice changing clinical trials.
Lawrence Fong, a genitourinary oncologist and expert in immunotherapy for solid tumors, was named scientific director of the Immunotherapy Integrated Research Center at Fred Hutchinson Cancer Center. He will begin the role July 1, 2024.
